Company Profile (AI Text)
Name: SofPulse, Inc.
Canonical URL: https://wefunder.com/sofpulse
Updated at: 2026-06-08T05:01:46Z

Tagline: Conquer Pain, End Addiction

Key claims:
- Total raised on Wefunder: 130395 | citation: https://wefunder.com/sofpulse#claim-total-raised
- Total investors: 177 | citation: https://wefunder.com/sofpulse#claim-total-investors

Verified facts:
- Total raised on Wefunder: 130395 | observed_at: 2026-06-08T05:01:46Z | expires_at: 2026-06-09T05:01:46Z
- Total investors: 177 | observed_at: 2026-06-08T05:01:46Z | expires_at: 2026-06-09T05:01:46Z

Computed metrics:
- total_amount_raised: 130395
- total_investors: 177
- team_size: 6
- featured_investor_count: 2
- faq_count: 5
- recent_post_count: 0

Quick facts:
- FDA-Cleared for Postoperative Pain and Edema & Listed on the Fed Supply System for sales to VA/DoD | citation: https://wefunder.com/sofpulse#claim-fact-1
- 50 million post-operative patients in the U.S. Hospital Market - Total Available Market: $25 Billion | citation: https://wefunder.com/sofpulse#claim-fact-2
- Robust Patent Portfolio: 18 Granted Patents Related to PEMF Therapies Including TBI, MS & Strokes | citation: https://wefunder.com/sofpulse#claim-fact-3
- Proj. Rev from US Hospital Market after receiving Medical Reimbursement: $1.25B/Yr (not guaranteed) | citation: https://wefunder.com/sofpulse#claim-fact-4
- Drug-free Solution for Eldercare/Assisted Living Facilities: Proj. Rev. 2026: $8.7M (not guaranteed) | citation: https://wefunder.com/sofpulse#claim-fact-5
- Received CE Mark: Expanding into Asia, Europe & South American Healthcare Markets | citation: https://wefunder.com/sofpulse#claim-fact-6
- Obtained Taiwan-FDA Approval and signed Exclusive Distributorship for $21mm in revenue over 6 years. | citation: https://wefunder.com/sofpulse#claim-fact-7
- Preparing to go public: filing a S-1 to register the CF Shares (not guaranteed) | citation: https://wefunder.com/sofpulse#claim-fact-8

FAQ:
- Q: What is the FSS Contract number or the SIN number so I can look up SofPulse in the MedSurg catalog? Thanks!
  A: Hi Erick, The SIN number, Product ID and Product Description are: A72; 1IVSP7.5x5; and SofPulse® 7.5” Single Patient Use (1 EA) (5 BX/CA) - PEMF Pulsed Electro Magnetic Field Therapy Device. To order Contact: Academy Medical - Customer service Call: 888.860.0561 Fax: 888.909.7767 Email: govservice@academymedical.net If you need any additional help, please email me directly at: acollier@sofpulseinc.com Sincerely, Alan Collier, CEO
- Q: I read the lengthy introduction and promotion of the product.However I really could not find prominent photos and serious explanations of how it looks and works.
  A: Hi Bruce, Please review our product site at SofPulse.com. Feel free to contact me directly at acollier@sofpulseinc.com with any questions... Thank you for your interest. Sincerely, Alan Collier, CEO
- Q: While the obvious benefits of post-operative pain reduction are wonderful, I'm wondering from a business point of view if a much. much larger target market in the future wouldn't be replacing meds as a solution for atherosclerotic inflammation and metaflammation---Jeff Bezos m...
  A: HI Jerry, Inflammation affects everything. Inflammation can cause cell death and organ failure if not treated and Metabolic inflammation, also known as metainflammation, is a key component in the progression of Non-Alcoholic Fatty Liver Disease (NAFLD) to Nonalcoholic Steatohepatitis (NASH). Because SofPulse® has proven clinical studies that show SofPulse® has effectively reduced inflammation after post-operative procedures, both preclinical and predicate studies have been performed in severa...
- Q: Hi Alan, would you please provide some additional details on your "Robust Patent Portfolio"? How many are granted, and in which countries, and do you also have ones pending? Do you foresee additional submissions? Thanks. Blessings
  A: Hi Kim, “Our "Robust Patent Portfolio”, the SofPulse® patent portfolio, consists of 18 granted patents in the US, Europe and several Asian markets in addition to 10 US trademarks. These patents cover the basic Pulsed Electromagnetic Field ("PEMF") technologies as well as use patents describing the use of SofPulse® in various therapeutic applications such as pain, Alzheimer’s, multiple sclerosis and other neurological uses. We have several new patent applications pending submission over the ne...
- Q: But how does it work exactly? What method, applied to skin, how and where? Exact details that make it work and how its effective. Lots of info, but nothing on actual details give any potential customer or investor why it works, answering this important question may help you ra...
  A: Hi Ted, Below are our frequently asked questions. If you have any other questions please email me directly at: acollier@sofpulseinc.com Sincerely, Alan Coliier, CEO SofPulse® Frequently Asked Questions: 1. What is SofPulse®? SofPulse® is a unique technology that utilizes targeted pulsed electromagnetic fields (tPEMF) therapy and is cleared by the FDA to treat pain and edema resulting from operative procedures. The SofPulse® device is simple, automated and easy to use. It has a compact design ...